Avinger, Inc. Share Price

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 02:00:00 11/05/2024 am IST 5-day change 1st Jan Change
3.798 USD -1.50% Intraday chart for Avinger, Inc. -2.62% +40.14%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 10.5M 876M Sales 2025 * 13.93M 1.16B Capitalization 6.02M 503M
Net income 2024 * -16M -1.34B Net income 2025 * -14M -1.17B EV / Sales 2024 * 0.57 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.43 x
P/E ratio 2024 *
-1.83 x
P/E ratio 2025 *
-2.81 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.50%
1 week-2.62%
Current month+1.55%
1 month-11.06%
3 months+35.92%
6 months+13.37%
Current year+40.14%
More quotes
1 week
3.60
Extreme 3.6
3.94
1 month
3.42
Extreme 3.42
4.25
Current year
2.50
Extreme 2.5
5.45
1 year
2.50
Extreme 2.5
18.00
3 years
2.50
Extreme 2.5
438.00
5 years
2.50
Extreme 2.5
1 710.00
10 years
2.50
Extreme 2.5
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 08/07/08
Chief Executive Officer 61 29/14/29
Director of Finance/CFO 41 01/20/01
Members of the board TitleAgeSince
Chief Executive Officer 61 29/14/29
Chairman 81 01/14/01
Director/Board Member 72 01/11/01
More insiders
Date Price Change Volume
10/24/10 3.798 -1.50% 6,418
09/24/09 3.856 +0.52% 3,042
08/24/08 3.836 +2.01% 1,002
07/24/07 3.76 -1.31% 1,743
06/24/06 3.81 -2.31% 5,129

Delayed Quote Nasdaq, May 11, 2024 at 02:00 am IST

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.798 USD
Average target price
5 USD
Spread / Average Target
+31.66%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW